Bharat Biotech announces phase 3 results of Covaxin, says it demonstrates interim clinical efficacy of 81%

India Today 2021-03-03

Views 6

Bharat Biotech has announced the results of phase 3 clinical trials of its Covid-19 vaccine candidate Covaxin. India's first Covid vaccine has demonstrated interim clinical efficacy of 81 per cent.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Covaxin Phase 3 Interim Trial Data: Results Show 81% Efficacy Rate, Claims Bharat Biotech
play
03:11

Covaxin Phase 3 Interim Trial Data: Results Show 81% Efficacy Rate, Claims Bharat Biotech
Bharat Biotech Concludes Final Analysis For Covaxin Efficacy | Covaxin News | Covid Vaccine
play
02:54

Bharat Biotech Concludes Final Analysis For Covaxin Efficacy | Covaxin News | Covid Vaccine
Bharat Biotech claims 77.8% efficacy for Covaxin in Phase 3 trials
play
02:22

Bharat Biotech claims 77.8% efficacy for Covaxin in Phase 3 trials
Covaxin efficacy determined after two doses: Bharat Biotech after Anil Vij tests Covid positive
play
04:41

Covaxin efficacy determined after two doses: Bharat Biotech after Anil Vij tests Covid positive
Covaxin Shows 81 Percent Efficacy In Phase 3 Clinical Trial | Bharat Biotech
play
05:46

Covaxin Shows 81 Percent Efficacy In Phase 3 Clinical Trial | Bharat Biotech
Bharat Biotech concludes phase 3 Covaxin trial, claims 77.8% efficacy against COVID 19 _ TV9News
play
00:53

Bharat Biotech concludes phase 3 Covaxin trial, claims 77.8% efficacy against COVID 19 _ TV9News
Covaxin Shows 81% Efficacy, Works Against UK Variant - Claims ICMR & Bharat Biotech|Oneindia Telugu
play
01:53

Covaxin Shows 81% Efficacy, Works Against UK Variant - Claims ICMR & Bharat Biotech|Oneindia Telugu
Bharat Biotech: कोवाक्सिन के फेज 3 ट्रायल का डाटा आया | Covaxin Phase 3 Trail 77.8 Percent Efficacy
play
01:40

Bharat Biotech: कोवाक्सिन के फेज 3 ट्रायल का डाटा आया | Covaxin Phase 3 Trail 77.8 Percent Efficacy
Bharat Biotech's Covaxin shows 78 per cent efficacy in phase-3 interim analysis
play
05:51

Bharat Biotech's Covaxin shows 78 per cent efficacy in phase-3 interim analysis
Covaxin price_ ₹600 for states, ₹1,200 for private hospitals, Bharat Biotech announces _ TV9News
play
01:02

Covaxin price_ ₹600 for states, ₹1,200 for private hospitals, Bharat Biotech announces _ TV9News
Bharat Biotech announces additional manufacturing of Covaxin in Ankeshwar, Gujarat _ TV9News
play
00:29

Bharat Biotech announces additional manufacturing of Covaxin in Ankeshwar, Gujarat _ TV9News
स्वदेशी वैक्सीन Covaxin पर बड़ी खबर | Bharat Biotech gets nod to move to phase 2 trials of Covaxin
play
03:07

स्वदेशी वैक्सीन Covaxin पर बड़ी खबर | Bharat Biotech gets nod to move to phase 2 trials of Covaxin